These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16514388)

  • 21. Current Therapeutic Options for Pancreatic Ductal Adenocarcinoma.
    Bisht S; Brossart P; Feldmann G
    Oncol Res Treat; 2018; 41(10):590-594. PubMed ID: 30286472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systemic chemotherapy for metastatic pancreatic cancer].
    Morizane C
    Nihon Shokakibyo Gakkai Zasshi; 2023; 120(8):651-657. PubMed ID: 37558411
    [No Abstract]   [Full Text] [Related]  

  • 23. Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.
    Tempero MA; Behrman S; Ben-Josef E; Benson AB; Cameron JL; Casper ES; Hoffman JP; Karl RC; Kim P; Koh WJ; Kuvshinoff BW; Melvin WS; Muscarella P; Sasson AR; Shibata S; Shrieve DC; Talamonti MS; Tyler DS; Vickers SM; Warren RS; Willett C; Wolff RA;
    J Natl Compr Canc Netw; 2005 Sep; 3(5):598-626. PubMed ID: 16194453
    [No Abstract]   [Full Text] [Related]  

  • 24. A review of systemic therapy for advanced pancreatic cancer.
    El-Rayes BF; Philip PA
    Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Not Available].
    Ackermann CJ; Güller U
    Ther Umsch; 2016 Nov; 73(9):511-514. PubMed ID: 27805490
    [No Abstract]   [Full Text] [Related]  

  • 26. Pancreatic islet cell tumor producing vasoactive intestinal polypeptide and calcitonin.
    Eskens FA; Roelofs EJ; Hermus AR; Verhagen CA
    Anticancer Res; 1997; 17(6D):4667-70. PubMed ID: 9494586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pancreatic metastasis from a Merkel cell carcinoma diagnosed by ultrasound-guided biopsy].
    García García de Paredes A; Tavío Hernández E; Foruny Olcina JR; Montans Araujo J; Boixeda de Miquel D; Albillos Martínez A
    Gastroenterol Hepatol; 2016; 39(6):395-7. PubMed ID: 26183234
    [No Abstract]   [Full Text] [Related]  

  • 28. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
    Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B;
    Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combination therapy with lentinan, mitomycin c, 5-fluorouracil and radiation--a case of long-term survival of pancreas cancer after palliative surgery].
    Kunitomo K; Kawahito M; Miura M; Komi N
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1342-4. PubMed ID: 2437863
    [No Abstract]   [Full Text] [Related]  

  • 30. Current status of chemotherapy in metastatic pancreatic cancer.
    Wils JA
    Anticancer Res; 1989; 9(4):1027-31. PubMed ID: 2683988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of combination chemotherapy of low-dose CDDP. Continuous infusion of 5-FU, and intermittent CPT-11 administration for 2 advanced pancreatic cancer cases with liver metastasis].
    Kobayashi A; Yamaguchi M
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1755-9. PubMed ID: 9757202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic advances in metastatic pancreatic adenocarcinoma and related cancers: focus on evidence-based and sequenced approaches to survival extension in metastatic pancreatic adenocarcinoma.
    Bekaii-Saab T; Yu K; Lima CMSR; Wolin EM
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):1-16. PubMed ID: 30807558
    [No Abstract]   [Full Text] [Related]  

  • 33. [Systemic chemotherapy for unresectable pancreatic cancer].
    Naruge D; Nagashima F; Furuse J
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():148-51. PubMed ID: 25857004
    [No Abstract]   [Full Text] [Related]  

  • 34. [Combined palliative subtotal pancreatectomy with resection of two hollow organs in cancer surgery].
    Basheev VKh; Ladur AI; Donets VL; Bogdanov VA
    Klin Khir; 2001 Apr; (4):57-8. PubMed ID: 11482200
    [No Abstract]   [Full Text] [Related]  

  • 35. Palliative chemotherapy for pancreatic adenocarcinoma: a retrospective cohort analysis of efficacy and toxicity of the FOLFIRINOX regimen focusing on the older patient.
    Berger AK; Haag GM; Ehmann M; Byl A; Jäger D; Springfeld C
    BMC Gastroenterol; 2017 Dec; 17(1):143. PubMed ID: 29207968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translating landmark trial-based evidence to the front lines of care for pancreatic cancer: the evolving trial-based and guideline-supported role for nanoliposomal topoisomerase inhibitors in metastatic pancreatic adenocarcinoma.
    Lima CMSR
    Clin Adv Hematol Oncol; 2018 Sep; 16 Suppl 17(9):3-5. PubMed ID: 30807559
    [No Abstract]   [Full Text] [Related]  

  • 37. Perioperative Therapy for Borderline Resectable Pancreatic Cancer: What and When?
    Kim MP; Katz MHG
    Ann Surg Oncol; 2019 Jun; 26(6):1596-1597. PubMed ID: 30680479
    [No Abstract]   [Full Text] [Related]  

  • 38. [Regional chemotherapy for pancreatic cancer].
    Tarazov PG
    Vopr Onkol; 2003; 49(2):139-44. PubMed ID: 12785192
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of Different Treatment Modalities on the Outcome of Pancreatic Cancer.
    Khan M; Ashraf MI; Syed AA; Hanif F
    J Coll Physicians Surg Pak; 2017 Aug; 27(8):470-474. PubMed ID: 28903837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unresectable adenocarcinoma of the pancreas.
    Klaassen DJ
    Cancer Invest; 2000; 18(4):406-7. PubMed ID: 10808378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.